A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts

被引:28
作者
Bossù, P
Vanoni, M
Wanke, V
Cesaroni, MP
Tropea, F
Melillo, G
Asti, C
Porzio, S
Ruggiero, P
Di Cioccio, V
Maurizi, G
Ciabini, A
Alberghina, L
机构
[1] Univ Milan Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy
[2] Ctr Ric Dompe, Laquila, Italy
关键词
CDC25(Mm); signal transduction therapy; fos-luciferase; oncogenes; GEF;
D O I
10.1038/sj.onc.1203539
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ras proteins are small GTPases playing a pivotal role in cell proliferation and differentiation, Their activation state depends on the competing action of GTPase Activating Proteins (GAP) and Guanine nucleotide Exchange Factors (GEF), A tryptophan residue (Trp1056 in CDC25(Mm)-GEF), conserved in all ras-specific GEFs identified so far has been previously shown to be essential for GEF activity. Its substitution with glutamic acid results in a catalytically inactive mutant, which is able to efficiently displace wild-ty pe GEF from p21(ras) and to originate a stable ras/GEF binary complex due to the reduced affinity of the nucleotide-free ras/GEF complex for the incoming nucleotide, We show here that this 'ras-sequestering property' can be utilized to attenuate ras signal transduction pathways in mouse fibroblasts transformed by oncogenic ras, In fact overexpression of the dominant negative GEF(W1056E), stable transfected cells strongly reduces intracellular ras GTP levels in k-ras transformed fibroblasts. Accordingly, the transfected fibroblasts revert to wild-type phenotype on the basis of morphology, cell cycle and anchorage independent growth. The reversion of the transformed phenotype is accompanied bar DNA endoreduplication, The possible use of dominant negative ras-specific GEFs as a tool to down-regulate tumor growth is discussed.
引用
收藏
页码:2147 / 2154
页数:8
相关论文
共 49 条
  • [1] Ras-independent transformation by v-Src
    Aftab, DT
    Kwan, J
    Martin, GS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) : 3028 - 3033
  • [2] Anborgh PH, 1999, MOL CELL BIOL, V19, P4611
  • [3] RAS GENES
    BARBACID, M
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 : 779 - 827
  • [4] PROTEINS REGULATING RAS AND ITS RELATIVES
    BOGUSKI, MS
    MCCORMICK, F
    [J]. NATURE, 1993, 366 (6456) : 643 - 654
  • [5] BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601
  • [6] GENETIC MECHANISMS IN TUMOR INITIATION AND PROGRESSION .10. THE RAS GENE FAMILY AND HUMAN CARCINOGENESIS
    BOS, JL
    [J]. MUTATION RESEARCH, 1988, 195 (03): : 255 - 271
  • [7] BOS JL, 1989, CANCER RES, V49, P4682
  • [8] A role for the Ras signalling pathway in synaptic transmission and long-term memory
    Brambilla, R
    Gnesutta, N
    Minichiello, L
    White, G
    Roylance, AJ
    Herron, CE
    Ramsey, M
    Wolfer, DP
    Cestari, V
    RossiArnaud, C
    Grant, SGN
    Chapman, PF
    Lipp, HP
    Sturani, E
    Klein, R
    [J]. NATURE, 1997, 390 (6657) : 281 - 286
  • [9] EPIDERMAL GROWTH-FACTOR REGULATES P21(RAS) THROUGH THE FORMATION OF A COMPLEX OF RECEPTOR, GRB2 ADAPTER PROTEIN, AND SOS NUCLEOTIDE EXCHANGE FACTOR
    BUDAY, L
    DOWNWARD, J
    [J]. CELL, 1993, 73 (03) : 611 - 620
  • [10] Increasing complexity of Ras signaling
    Campbell, SL
    Khosravi-Far, R
    Rossman, KL
    Clark, GJ
    Der, CJ
    [J]. ONCOGENE, 1998, 17 (11) : 1395 - 1413